Source: RSC Advances. Unidade: IFSC
Subjects: NEOPLASIAS MAMÁRIAS, ANTINEOPLÁSICOS, PLANEJAMENTO DE FÁRMACOS
ABNT
SILVA, Thiago Sabino da et al. Discovery of indolizine lactones as anticancer agents and their optimization through late-stage functionalization. RSC Advances, v. 2023, n. 29, p. 20264-20270 + supplementary information: 1-128, 2023Tradução . . Disponível em: https://doi.org/10.1039/d3ra03395c. Acesso em: 13 nov. 2024.APA
Silva, T. S. da, Souza, M. da S., Andricopulo, A. D., & Coelho, F. A. S. (2023). Discovery of indolizine lactones as anticancer agents and their optimization through late-stage functionalization. RSC Advances, 2023( 29), 20264-20270 + supplementary information: 1-128. doi:10.1039/d3ra03395cNLM
Silva TS da, Souza M da S, Andricopulo AD, Coelho FAS. Discovery of indolizine lactones as anticancer agents and their optimization through late-stage functionalization [Internet]. RSC Advances. 2023 ; 2023( 29): 20264-20270 + supplementary information: 1-128.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1039/d3ra03395cVancouver
Silva TS da, Souza M da S, Andricopulo AD, Coelho FAS. Discovery of indolizine lactones as anticancer agents and their optimization through late-stage functionalization [Internet]. RSC Advances. 2023 ; 2023( 29): 20264-20270 + supplementary information: 1-128.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1039/d3ra03395c